-
Walgreens was the 12th and final defendant in the state's legal battle against opioid manufacturers, distributors and pharmaceutical companies it holds responsible for the epidemic.
-
The lawsuit centers on settlements the attorney general's office reached with companies that manufacture, distribute or sell opioids — and similar lawsuits that the hospital systems and school board have filed.
-
The settlements left Walgreens as the sole defendant in a lawsuit that targeted businesses involved in all aspects of the opioid industry. A Pasco County judge is scheduled to begin jury selection next week.
-
The companies, including Johnson & Johnson and McKesson, will admit no wrongdoing. Billions of dollars in payouts will fund drug treatment and harm reduction programs.
-
This ruling and a recent state court in California raise questions about thousands of opioid lawsuits filed against Big Pharma.
-
The money would be spread over a period of 18 years, starting next April.
-
The decision by a federal bankruptcy judge grants members of the family who own Purdue Pharma, maker of OxyContin, sweeping protection from any liability for the opioid crisis.
-
Attorney General Ashley Moody says the money will be spent on drug prevention measures as well as opioid treatment and recovery services.
-
Four big drug companies would pay out $26 billion to dozens of states over the next 17 years.
-
The New York attorney general says Johnson & Johnson has agreed to pay $230 million to settle claims that the pharmaceutical giant helped fuel the opioid crisis.